Canada: Time For Change? Potential Impact Of Canada’s Trade Negotiations On Pharma Patents

Bringing a new drug to market is a costly and time-consuming endeavour. It is a process inherent with the risk of failure. In recognition of this, patent and regulatory regimes in many jurisdictions provide certain compensatory schemes to innovator companies to offset the investment made in developing new drugs.

Data protection, for example, protects the data submitted to regulatory authorities by innovator companies during the new drug approval process by preventing generic companies from relying on this data for a specified length of time (generally five to 12 years).

Patent term extension, such as that provided by European supplementary protection certificates (SPCs) and U.S. patent term extensions, compensates patentees for at least part of the patent term lost while a drug goes through regulatory approval by extending the term of a patent that covers the drug in question (typically by up to five years).

Finally, linkage schemes that link the patent regime with the drug regulatory regime allow innovator companies that apply for regulatory approval of a new drug to list patents relating to the drug with the relevant regulatory authority. Any company subsequently applying for approval of a generic version of the new drug must address each listed patent by (i) agreeing not to market their product until all the patents expire, (ii) asserting non-infringement, or (iii) challenging the validity of the patents. A response by the innovator company to an assertion of non-infringement or a validity challenge automatically triggers a temporary injunction period preventing approval of the generic drug while the injunction is in place (typically to provide a time period for courts to hear and decide the infringement and validity issues).

Canada's Patented Medicines (Notice of Compliance) Regulations provide for such a linkage scheme. In addition, as a result of Canada's TRIPS and NAFTA obligations, the Food and Drug Regulations provide a data protection scheme that allows for a total of eight years data protection for innovative drugs, including biologics. Compensatory patent term extensions on the other hand remain notably absent from Canada's patent and regulatory systems and put Canada at odds with major trading partners, such as the U.S. and the European Union (EU).

Canada is, however, currently negotiating a Comprehensive Economic and Trade Agreement (CETA) with the EU and the opportunities for Canada are significant. For example, Canadian businesses and products would have improved access to the European market of approximately 500 million people. In return for this access, the draft CETA contains a number of provisions relating to intellectual property and regulatory laws, including an obligation for Canada to implement a patent term extension scheme similar to that found in Europe. Europe is making a simple and fair request. It wants Canada to implement patent term extension provisions that mirror the SPC system in Europe.

Europe's position is that European pharmaceutical companies operating in Canada should be provided with the same protection as a Canadian pharmaceutical company operating in Europe. Europe provides a maximum extension of five years to the patent term to compensate for the regulatory approval process, with the possibility of a further six month paediatric extension where the innovator company conducts pre-approved clinical studies in children.

In addition to negotiations with the EU, Canada has recently formally joined the Trans-Pacific Partnership (TPP) trade negotiations, of which the other participants are currently Australia, Brunei, Chile, Malaysia, Mexico, New Zealand, Peru, Singapore, the U.S. and Vietnam. Both Japan and South Korea have also expressed an interest in joining the TPP, with Japan making a formal announcement to this effect on March 15, 2013. As is the case for a CETA with the EU, a TPP agreement would potentially improve market access for Canadian businesses and products, in this case to the rapidly developing Asia-Pacific markets.

The draft TPP Agreement, like the draft CETA, includes provisions covering intellectual property rights. According to official documents, the proposals under discussion relate to various areas of intellectual property, including patents and data required for the approval of certain regulated products. A number of documents relating to the TPP negotiations have been leaked into the public domain, including a proposal on patent protection tabled by the U.S. in 2011. This proposal included requirements for all members to implement both data protection and linkage schemes, as well as compensatory patent term extensions. The proposal apparently faced severe opposition from other members of the TPP and was subsequently withdrawn.

Intellectual property issues are acknowledged to be some of the more challenging in the TPP negotiations and official reports indicate that they will be a focus of the next round of negotiations that take place from May 15-24, 2013, in Lima, Peru. The U.S. is likely to be a strong voice in these negotiations and should either Japan or South Korea, who both provide compensatory patent term extensions, join the TPP, the U.S. position on this aspect of patent protection may be strengthened. While some of the TPP members already provide some form of compensatory patent term extension (see Table), a significant number do not, and some, such as Peru, have already successfully negotiated around having to implement such schemes in bilateral agreements with the U.S. As such, Canada may find support within the TPP group for a position against implementation of patent term extensions. This may, however, be a moot point if a CETA is signed with the EU that requires Canada to implement such extensions.

In summary, as the result of these two major ongoing trade negotiations, Canada is facing considerable pressure to implement patent term extensions as a complement to its existing linkage and data protection schemes. It will be interesting to see if 2013 brings about a change in Canada's current position.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions